UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1201-1214

2019

Volltextzugriff (PDF)

Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial

Clinical gastroenterology and hepatology, 2022-12, Vol.20 (12), p.2858-2867.e5

2022

Volltextzugriff (PDF)

AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD

Respiratory medicine, 2012-04, Vol.106 (4), p.531-539

2012

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease, 2017-09, Vol.14 (5), p.476-483

2017

Volltextzugriff (PDF)

Actuarial valuations to monitor defined benefit pension funding

British Actuarial Journal, 2020-01, Vol.25, Article e14

O’Brien, Christopher D.

2020

Volltextzugriff (PDF)

Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: A randomized controlled trial

Journal of allergy and clinical immunology, 2012-08, Vol.130 (2), p.362-367.e9

2012

Volltextzugriff (PDF)

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

Inflammatory bowel diseases, 2021-06, Vol.27 (7), p.994-1007

2021

Volltextzugriff (PDF)

Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy

Alimentary pharmacology & therapeutics, 2020-12, Vol.52 (11-12), p.1658-1675

2020

Volltextzugriff (PDF)

Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration

American Journal of Physiology: Cell Physiology, 2002-05, Vol.282 (5), p.C1181-C1190

2002

Volltextzugriff (PDF)

Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma : A randomised clinical trial

Drugs (New York, N.Y.), 2006-01, Vol.66 (17), p.2235-2254

2006

Volltextzugriff (PDF)

Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel

Current medical research and opinion, 2009-06, Vol.25 (6), p.1563-1571

2009

Volltextzugriff (PDF)

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma

Clinical therapeutics, 2007-05, Vol.29 (5), p.823-843

2007

Volltextzugriff (PDF)

The exercise of discretion on commutation factors in defined benefit schemes: time for change?

British Actuarial Journal, 2024-01, Vol.29, Article e8

O’Brien, Christopher D.

2024

Volltextzugriff (PDF)

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

Journal of Crohn's and colitis, 2018-11, Vol.12 (10), p.1158-1169

2018

Volltextzugriff (PDF)

Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration

American Journal of Physiology: Cell Physiology, 2004-10, Vol.287 (4), p.C1103-C1113

2004

Volltextzugriff (PDF)

Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial

Annals of allergy, asthma, & immunology, 2011-09, Vol.107 (3), p.258-265.e2

2011

Volltextzugriff (PDF)

PECAM-1–dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization

Blood, 2003-04, Vol.101 (7), p.2816-2825

2003

Volltextzugriff (PDF)

A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium

Chronic obstructive pulmonary disease, 2012-04, Vol.9 (2), p.111-120

2012

Volltextzugriff (PDF)

Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment

The Journal of immunology (1950), 2000-01, Vol.164 (1), p.452-462

2000

Volltextzugriff (PDF)

Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma

Pediatrics (Evanston), 2010-09, Vol.126 (3), p.e565-e575

2010

Volltextzugriff (PDF)

Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma

The Journal of asthma, 2012-02, Vol.49 (1), p.70-77

2012

Volltextzugriff (PDF)

Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

Crohn's & colitis 360, 2020-10, Vol.2 (4), p.otaa063-otaa063

2020

Volltextzugriff (PDF)

Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients

Allergy and asthma proceedings, 2008-09, Vol.29 (5), p.499-516

2008

Volltextzugriff (PDF)

Intrapatient symptom variability in adults and children with asthma: results of a survey

Advances in therapy, 2005-09, Vol.22 (5), p.488-497

2005

Volltextzugriff (PDF)

The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children

Allergy and asthma proceedings, 2010-01, Vol.31 (1), p.26

2010

Volltextzugriff (PDF)

1 – 25 von 781

Suche als RSS-Feed

Aktive Filter

SpracheRussisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(724)
Mit Volltextzugriff
(665)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial

AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD

A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease

Actuarial valuations to monitor defined benefit pension funding

Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: A randomized controlled trial

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy

Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration

Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma : A randomised clinical trial

Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma

The exercise of discretion on commutation factors in defined benefit schemes: time for change?

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration

Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial

PECAM-1–dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization

A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium

Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment

Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma

Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma

Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients

Intrapatient symptom variability in adults and children with asthma: results of a survey

The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children

Aktive Filter

Suchergebnisse filtern